Details of the Drug Reposition

General Information of This Drug (ID: DMSYPNW)

Drug Name
Ranibizumab   DMSYPNW
Synonyms Ranibizumab (nasal spray, hereditary hemorrhagic telangiectasia)
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Central retinal vein occlusion with macular edema DISKBNZP N.A. Approved [1]
Exudative age-related macular degeneration DIS88DJO 9B78.3Z Approved [2]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hereditary hemorrhagic telangiectasia DISXTDNT LA90.00 Investigative [3]
------------------------------------------------------------------------------------

References

1 A review of neovascular glaucoma. Etiopathogenesis and treatment. Rom J Ophthalmol. 2021 Oct-Dec;65(4):315-329.
2 Age-related macular degeneration: anti-vascular endothelial growth factor treatment. BMJ Clin Evid. 2016 Feb 24;2016:0701.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6779).